BioCryst Pharmaceuticals | 営業利益



Operating Profit 変化する 日付
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Chugai Pharma JPY 136.65B 13.25B 2025-03
Daiichi Sankyo JPY 83.61B 22.2B 2025-03
DBV Technologies USD -26618000 2.76M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Incyte USD 205.17M 96.34M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



BioCryst Pharmaceuticals 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jul 2025.